Merit Medical initiated with a Buy at BTIG

BTIG initiated coverage of Merit Medical (MMSI) with a Buy rating and $107 price target Merit is a global medical device company with a “comprehensive” portfolio of products that are used across a broad range of interventional procedures, the analyst tells investors in a research note. The firm sees the company’s end markets remaining “healthy” given rising cardiovascular disease prevalence and Merit ‘s stable competitive position. With forward expectations achievable and the stock trading at one standard deviation below its historical average, current levels offer an attractive entry point, contends BTIG.